Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
In this study, we aim at assessing the benefits of dietary supplementation with ABB i5 and ABB C24, a combination of the the prebiotic ABB i5 and the postbiotic ABB C22, on the gut microbiota of people with constipation and on their gastrointestinal well-being.
Epistemonikos ID: c291c5f7ea4051daa40266ecfb2070f740e49461
First added on: Jan 01, 2025